Economic evaluation seeks threshold to support decision-making

• Published in: Revista espanola de salud publica Vol. 89; no. 6; p. 537
• Main Authors: García-Lorenzo, Borja, Vallejo-Torres, Laura, Trujillo-Martín, María Mar, Perestelo-Pérez, Lilisbeth, Valcárcel-Nazco, Cristina, Serrano Aguilar, Pedro
• Format: Journal Article
• Language: Spanish
• Published: Spain 01.11.2015
• Subjects: Cost-Benefit Analysis; Decision Making; Health Care Costs; Humans; Quality-Adjusted Life Years; Spain; Spain
• ISSN: 2173-9110
• DOI: 10.4321/S1135-57272015000600002

To incorporate economic evaluation into decision-making, we need to know how much a health system is willing and able to invest in a quality-adjusted life year (QALY). In Spain, the figure of €30,000 per QALY as cost-effectiveness (CE) threshold has been widely cited. However, as in most health systems, no value has been formally adopted; mainly because of the arbitrariness, the lack of theoretical and scientific basis, and the controversy around its estimation and what the threshold should represent. Based on a systematic review of empirical studies on the estimation of the CE threshold undertaken by this research team, we conducted a critical appraisal of the state of the art, using a Delphi with the participation of 13 national experts. This paper contributes to assess the research progress on the CE threshold in Spain, to consider its utility in the decision making process supported by economic evaluation, and to propose further research to improve what has been achieved so far.